Jump to content

PPIs double covid risk


Recommended Posts

I remember this coming out early on and tjoght I read it was debunked or at least found that PPI use in covid pts were not significantly affected... I can try to find the followup article.

 

Edited to add: I take it back! [emoji23] ok... Found a recent one saying that PPI do increase risk of covid 19 by up to 2x as likely while H2RAs carry a 15% less likelihood of infection.

 

It's thought to be from the reduced acidity that promotes more susceptibility to enteric pathogens which SARS-cov2 is.

 

https://www.medscape.com/viewarticle/933645

 

https://www.medscape.com/viewarticle/933697

 

Hmmm... Gotta have that conversation with my GERDies!

 

Sent from my SM-G975U using Tapatalk

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Link to comment
Share on other sites

Great. Another hit piece on PPI’s. Reminds me of the dementia fiasco that still plaques the medication. Not discrediting the preliminary research but it does appear to be, once again, correlation rather than causation. Nobody should be on a ppi without necessity. That being said, there are very necessary circumstances including Barrett’s, ulcers, esophagitis, pylori, etc. I have lost count how many pts I’ve had lately that can not acquire famotidine because it is out of stock (largely due to its unproven benefit in covid as with other drugs). These are people that actually need this drug clinically and it’s being sucked up by folks with zero clinical reason or symptom. There a few options remaining with similar side effect profiles.

  • Like 1
  • Upvote 1
Link to comment
Share on other sites

Great. Another hit piece on PPI’s. Reminds me of the dementia fiasco that still plaques the medication. Not discrediting the preliminary research but it does appear to be, once again, correlation rather than causation. Nobody should be on a ppi without necessity. That being said, there are very necessary circumstances including Barrett’s, ulcers, esophagitis, pylori, etc. I have lost count how many pts I’ve had lately that can not acquire famotidine because it is out of stock (largely due to its unproven benefit in covid as with other drugs). These are people that actually need this drug clinically and it’s being sucked up by folks with zero clinical reason or symptom. There a few options remaining with similar side effect profiles.

Yeah I remember the PPI and the Ranitidine hoopla when I worked in GI last year. I always give my pts the choice but I fully go over risks of stopping acid control esp PPI like Barret etc. Esp if my pt has esophageal erosions. It's like the ARB scare a few years ago too. I agree that this may likely be more correlary vs causative as with everything else in medicine, we gotta have the conversation with our pts and ultimately have them decide with our guidance.  

Sent from my SM-G975U using Tapatalk

 

 

 

 

 

  • Like 2
Link to comment
Share on other sites

Nationwide back order on famotidine as of today thanks to the rumors. Nobody wants to use Tagamet. This leaves us with PPIs for acid suppression. Of course there’s always carafate but its efficacy only goes so far in uncomplicated GERD. Roll out the baclofen and low dose elavil. 

Link to comment
Share on other sites

So here's the piece...

https://journals.lww.com/ajg/Documents/AJG-20-1811_R1(PUBLISH AS WEBPART).pdf

It was an online survey and there were quite a few discrepancies with the information entered (i.e. a large # of individuals with high school education or less claiming >$200k/yr) making one wonder how accurate the information was.

With that being said, physiologically it makes sense.  Unfortunately we have evidence of a great number of things that make physiologic sense which don't actually play out in the real world. 

Correlation ain't always causation amiright?  Think about who else is probably on PPIs besides your GERDers, most elderly folk who are on DAPT post PCI, diabetics, and oftentimes those individuals who are chronically unwell. 

But who knows? If there's a safe alternative maybe consider it?  Also consider that the lead author is the co-editor in chief of the journal in which it was published...

  • Like 2
  • Upvote 1
Link to comment
Share on other sites

Join the conversation

You can post now and register later. If you have an account, sign in now to post with your account.

Guest
Reply to this topic...

×   Pasted as rich text.   Paste as plain text instead

  Only 75 emoji are allowed.

×   Your link has been automatically embedded.   Display as a link instead

×   Your previous content has been restored.   Clear editor

×   You cannot paste images directly. Upload or insert images from URL.

×
×
  • Create New...

Important Information

Welcome to the Physician Assistant Forum! This website uses cookies to ensure you get the best experience on our website. Learn More